Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Flexion Therapeutics Inc (NASDAQ:FLXN)

24.82
Delayed Data
As of Dec 12
 -0.09 / -0.36%
Today’s Change
16.51
Today|||52-Week Range
32.25
+30.49%
Year-to-Date

Today’s Trading

Previous close24.91
Today’s open24.95
Day’s range24.18 - 25.28
Volume1,106,630
Average volume (3 months)1,302,127
Market cap$935.1M
Data as of 4:00pm ET, 12/12/2017

Growth & Valuation

Earnings growth (last year)-32.09%
Earnings growth (this year)-33.92%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.22

Competitors

 Today’s
change
Today’s
% change
ENTAEnanta Pharmaceutica...+0.01+0.02%
SPPISpectrum Pharmaceuti...+0.32+1.76%
EGRXEagle Pharmaceutical...-2.16-3.62%
ITCIIntra-Cellular Thera...-0.01-0.07%
Data as of 4:00pm ET, 12/12/2017

Financials

Next reporting dateMarch 28, 2018
EPS forecast (this quarter)-$1.11
Annual revenue (last year)$0.00
Annual profit (last year)-$71.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer, CFO &
Director
Michael D. Clayman
Chief Scientific Officer
Neil Bodick
Corporate headquarters
Burlington, Massachusetts

Forecasts